Literature DB >> 20110824

Cognitive and behavioral characterization of the Potocki-Lupski syndrome (duplication 17p11.2).

Diane E Treadwell-Deering1, M Paige Powell, Lorraine Potocki.   

Abstract

OBJECTIVE: To describe the cognitive and behavioral phenotypic features of the Potocki-Lupski syndrome (duplication 17p11.2), a recently recognized syndrome with multiple congenital anomalies and developmental delays.
METHOD: Fifteen subjects were enrolled in an extensive multidisciplinary clinical protocol. Cognitive and behavior evaluations included a parent-report medical and psychological history form, intellectual assessment and assessments of adaptive behavior, executive functioning, and maladaptive behavior and emotions. Eight of the families completed an Autism Diagnostic Interview-Revised and Autism Diagnostic Observation Schedule-Generic.
RESULTS: The majority of patients (13 of 15) presented with intellectual disability. Moreover, the majority of patients also had moderate to severe behavioral difficulties, including atypicality, withdrawal, anxiety, and inattention. Many patients characterized also presented with autistic symptom pictures, some of whom (10 of 15) met diagnostic criteria for an autistic spectrum disorder, namely autistic disorder or pervasive developmental disorder not otherwise specified.
CONCLUSION: This work expands on the behavioral phenotype of duplication 17p11.2 (Potocki-Lupski syndrome). Further phenotypic analysis will aid in clinical diagnosis, counseling, and management of this newly characterized microduplication syndrome. The association between this syndrome and autistic spectrum disorder may contribute to further understanding the etiology of the pervasive developmental disorders.

Entities:  

Mesh:

Year:  2010        PMID: 20110824     DOI: 10.1097/DBP.0b013e3181cda67e

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  26 in total

1.  The severe end of the spectrum: Hypoplastic left heart in Potocki-Lupski syndrome.

Authors:  Amarilis Sanchez-Valle; Mary Ella Pierpont; Lorraine Potocki
Journal:  Am J Med Genet A       Date:  2011-01-13       Impact factor: 2.802

2.  Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders.

Authors:  Rui Luo; Stephan J Sanders; Yuan Tian; Irina Voineagu; Ni Huang; Su H Chu; Lambertus Klei; Chaochao Cai; Jing Ou; Jennifer K Lowe; Matthew E Hurles; Bernie Devlin; Matthew W State; Daniel H Geschwind
Journal:  Am J Hum Genet       Date:  2012-06-21       Impact factor: 11.025

Review 3.  Neurodevelopmental Disorders Associated with Abnormal Gene Dosage: Smith-Magenis and Potocki-Lupski Syndromes.

Authors:  Juanita Neira-Fresneda; Lorraine Potocki
Journal:  J Pediatr Genet       Date:  2015-09-28

Review 4.  Structural variation mutagenesis of the human genome: Impact on disease and evolution.

Authors:  James R Lupski
Journal:  Environ Mol Mutagen       Date:  2015-04-17       Impact factor: 3.216

5.  Objective measures of sleep disturbances in children with Potocki-Lupski syndrome.

Authors:  Kevin Kaplan; Caroline McCool; James R Lupski; Daniel Glaze; Lorraine Potocki
Journal:  Am J Med Genet A       Date:  2019-07-24       Impact factor: 2.802

6.  Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS.

Authors:  Feng Zhang; Lorraine Potocki; Jacinda B Sampson; Pengfei Liu; Amarilis Sanchez-Valle; Patricia Robbins-Furman; Alicia Delicado Navarro; Patricia G Wheeler; J Edward Spence; Campbell K Brasington; Marjorie A Withers; James R Lupski
Journal:  Am J Hum Genet       Date:  2010-02-25       Impact factor: 11.025

7.  Opposing phenotypes in mice with Smith-Magenis deletion and Potocki-Lupski duplication syndromes suggest gene dosage effects on fluid consumption behavior.

Authors:  Detlef H Heck; Wenli Gu; Ying Cao; Shuhua Qi; Melanie Lacaria; James R Lupski
Journal:  Am J Med Genet A       Date:  2012-09-18       Impact factor: 2.802

8.  Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior.

Authors:  Paulina Carmona-Mora; Katherina Walz
Journal:  Curr Genomics       Date:  2010-12       Impact factor: 2.236

9.  Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Carolina A Encina; Cesar P Canales; Lei Cao; Jessica Molina; Pamela Kairath; Juan I Young; Katherina Walz
Journal:  BMC Mol Biol       Date:  2010-08-25       Impact factor: 2.946

10.  Stress and well-being among parents of children with Potocki-Lupski syndrome.

Authors:  Rebecca D Carter; Marianna Raia; Linda Ewing-Cobbs; Michael Gambello; S Shahrukh Hashmi; Susan K Peterson; Patricia Robbins-Furman; Lorraine Potocki
Journal:  J Genet Couns       Date:  2013-05-25       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.